tumor infiltrating lymphocyte(English)
- personalized treatment for cancer is based on the infusion of autologous T lymphocytes that have been obtained directly from surgically removed autologous tumors and then expanded in culture with the use of interleukin-2 stimulation. Both preconditioning lymphodepletion with high-dose, nonmyeloablative chemotherapy and the intravenous administration of high-dose interleukin-2 after cell transfer have been instrumental in the success of TIL adoptive cell therapy
- CAR, CAR-T, ICI, IL-2, CNB, DFS, PD-L1, PST, TNBC, FDA, TILV, AF, BiTE, CD19, CHIP, COPD, CTRCD, CXC, HFpEF, IVC, LVEDP, LVEF, NP, PAH, PVOD, RT, RVF, TKI, TTR, VEGFi
- Oncology, Therapeutic approaches, Personalized approach, Chemotherapy, Cardiology
- https://doi.org…56/NEJMe2214655
- https://doi.org…2282-017-0781-0
- https://www.can…herapy-melanoma
- https://doi.org…1002/ejhf.70005